We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$36.7B
AUM Growth
+$816M
Cap. Flow
+$358M
Cap. Flow %
0.97%
Top 10 Hldgs %
22.15%
Holding
3,794
New
138
Increased
1,226
Reduced
1,484
Closed
173

Sector Composition

Rank Sector Weight
1 Financials 10.84%
2 Technology 10.72%
3 Industrials 10.16%
4 Healthcare 8.91%
5 Consumer Staples 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
3526
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1K ﹤0.01%
148
-1,608
-92% -$15.4K
BEST
3527
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$1K ﹤0.01%
9
SCX
3528
DELISTED
The L.S. Starrett Company
SCX
$1K ﹤0.01%
124
-579
-82% -$3.39K
CMLS
3529
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$1K ﹤0.01%
100
IMGN
3530
DELISTED
Immunogen Inc
IMGN
$1K ﹤0.01%
563
+432
+330% +$1.15K
RPT
3531
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1K ﹤0.01%
71
ZYNE
3532
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1K ﹤0.01%
100
RETA
3533
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1K ﹤0.01%
+15
New +$1.27K
BLCM
3534
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1K ﹤0.01%
100
BIOC
3535
DELISTED
Biocept, Inc.
BIOC
$1K ﹤0.01%
3
TMDI
3536
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$1K ﹤0.01%
500
LCI
3537
DELISTED
Lannett Company, Inc.
LCI
$1K ﹤0.01%
+23
New +$782
ECOM
3538
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$1K ﹤0.01%
147
-147
-50% -$1.35K
GBT
3539
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1K ﹤0.01%
+11
New +$573
RRD
3540
DELISTED
RR Donnelley & Sons Co.
RRD
$1K ﹤0.01%
491
XLRN
3541
DELISTED
Acceleron Pharma
XLRN
$1K ﹤0.01%
+19
New +$824
EBSB
3542
DELISTED
Meridian Bancorp, Inc.
EBSB
$1K ﹤0.01%
+61
New +$1.11K
ZAGG
3543
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$1K ﹤0.01%
232
-2,407
-91% -$15.6K
MVC
3544
DELISTED
MVC Capital, Inc.
MVC
$1K ﹤0.01%
118
-117
-50% -$1.07K
NBRV
3545
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
2
RST
3546
DELISTED
ROSETTA STONE INC
RST
$1K ﹤0.01%
106
NE
3547
DELISTED
Noble Corporation
NE
$1K ﹤0.01%
+931
New +$1.59K
AKRX
3548
DELISTED
Akorn Inc
AKRX
$1K ﹤0.01%
393
-16
-4% -$57
CTST
3549
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$1K ﹤0.01%
+1,145
New +$2.56K
DERM
3550
DELISTED
Dermira, Inc.
DERM
$1K ﹤0.01%
+133
New +$1.11K

Similar funds

US Bancorp's Q3 2019 Portfolio in Review

As of Q3 2019, US Bancorp held 3,794 positions worth $36.7B, up 2.3% from $35.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

US Bancorp's Q3 2019 filing shows 138 new, 1,226 increased, 1,484 reduced and 173 closed positions. Its largest new stake was Enphase Energy: 79,689 shares worth $1.77M. The largest sale was Vanguard Total Stock Market ETF, an estimated $43.8M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Industrials.

  • US Bancorp's largest Q3 2019 buy was Enphase Energy: 79,689 shares worth $1.77M.
  • US Bancorp added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $219M increase.
  • US Bancorp's biggest Q3 2019 reduction was Vanguard Total Stock Market ETF, cutting an estimated $43.8M.
  • US Bancorp fully exited iShares iBonds Sep 2019 Term Muni Bond ETF in Q3 2019, selling an estimated $22M.
  • US Bancorp's ten largest holdings make up 22% of its $36.7B portfolio in Q3 2019.
  • US Bancorp opened 138 new positions and closed 173 in Q3 2019.
  • US Bancorp's portfolio value rose 2.3% quarter-over-quarter to $36.7B.

Based on US Bancorp's 13F filing for Q3 2019, filed 8 Nov 2019.